On Tuesday, October 15th, partner  Vern Norviel will be speaking on the panel, Commercial Translation of Gene Editing, at the 7th International Conference on CRISPR Technologies conference in San Diego, CA. CRISPR has impacted commercial markets in the areas of therapeutics, diagnostics, industrial bio, and agriculture. While there have been a number of successful examples of translation from the lab to the market, many opportunities remain for innovation to address ongoing translational challenges.

CRISPR 2024 is an exclusive conference that unites leaders from industry, government agencies, and academia to discuss the latest advancements in genome editing technologies. The program brings together experts from diverse fields to discuss how to safely and effectively translate these cutting-edge technologies to patients, while remaining mindful of the ethical implications.